[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Ilya Lukin\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":50},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":10,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":21,"studyType":22,"phases":4,"briefSummary":23,"conditions":24,"keywords":28,"overallStatus":38,"whyStopped":4,"lastUpdateSubmitDate":39,"lastUpdatePostDateStruct":40,"startDateStruct":43,"completionDateStruct":45,"leadSponsor":47,"locationsCount":5},"100614408",false,"NCT07279207","PACE-AF: Prospective Analysis of Cardiac Electrostimulation and Atrial Fibrillation","Prospective Analysis of Cardiac Electrostimulation and Atrial Fibrillation (PACE-AF)","PACE-AF","Inclusion Criteria:\n\n* • Age ≥ 18 years\n\n  * Implantation of a dual-chamber permanent pacemaker\n  * Ability to provide informed consent\n  * Willingness to participate in long-term follow-up\n\nExclusion Criteria:\n\n* • Single-chamber pacemaker or Cardiac Resynchronization Therapy device at baseline\n\n  * Life expectancy \\\u003C 1 year due to non-cardiac comorbidities\n  * Inability to comply with follow-up visits or device interrogation\n  * Participation in another clinical trial that could interfere with study endpoints","ALL","18 Years",{"count":19,"type":20},500,"ESTIMATED","3 Years","OBSERVATIONAL","PACE-AF is a prospective, observational patient registry designed to evaluate the impact of pacemaker algorithms on atrial fibrillation (AF) incidence, progression, and clinical outcomes in patients implanted with dual-chamber pacemakers. The registry aims to include 400-500 patients with longitudinal follow-up. Primary outcomes are progression to permanent AF and all-cause mortality. Secondary outcomes include quality of life, hospitalization, and cardiovascular events.",[25,26,27],"Atrial Fibrillation","Sick Sinus Syndrome","Atrioventricular Block",[29,30,31,32,33,34,35,36,37],"Pacemaker","Dual-chamber pacing","Pacemaker algorithms","Conduction system pacing","His bundle pacing","Left bundle branch pacing","Catheter ablation","Cryoablation","Arrhythmia prevention","NOT_YET_RECRUITING","2025-11-30",{"date":41,"type":42},"2025-12-12","ACTUAL",{"date":44,"type":20},"2025-12",{"date":46,"type":20},"2028-12",{"name":48,"class":49},"Ilya Lukin","OTHER",""]